PATHOCIL
DICLOXACILLIN SODIUM
Approval overview PATHOCIL is listed in Drugs@FDA under application 050011 (NDA).
Marketing status: Discontinued Active ingredient DICLOXACILLIN SODIUM Form and strength CAPSULE;ORAL - EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor WYETH AYERST Submission history Latest submission status date: 1991-04-10 00:00:00.
Structured Monograph
Clinical summary
Approval overview PATHOCIL is listed in Drugs@FDA under application 050011 (NDA). Marketing status: Discontinued Active ingredient DICLOXACILLIN SODIUM Form and strength CAPSULE;ORAL - EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor WYETH AYERST Submission history Latest submission status date: 1991-04-10 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.